- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02024854
Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation
January 19, 2023 updated by: Norwegian University of Science and Technology
Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation. A Randomized Controlled Trial
The aim of the study is to investigate physiological response, social/emotional response and general movements in preterm infants when they are given skin-to-skin contact with the mother (intervention) or standard care (incubator) right after delivery.
Preterm infants will be randomized to either intervention or standard care group.
Data on body temperature, blood glucose, hart rate, respiration rate and oxygen saturation will be obtained.
In addition the infant will be video-recorded during the first 24 hours and at three months of age for analysis of the general movements.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Power calculations are based on a difference in Bayley Scale of Infant Development III, cognitive scale at two years corrected age of about 7,5 mean score =0.5 SD (α=0,05, β=0.80).
Based on this analysis, 64 preterm infants are needed in each group to yield statistic significance.
Allowing for withdrawals, the sample size is set to 68 in each group.
Study Type
Interventional
Enrollment (Actual)
108
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 7 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Preterm infants at 28-32 weeks of gestation (born 12-8 weeks before term)
Exclusion Criteria:
- Infants who need immediate medical interventions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: skin-to-skin
immediately after birth the baby is laid on mother's chest for as long as justifiable medically to max 2 hours.
|
|
Active Comparator: standard care
after birth the baby is transferred to the neonatal intensive care unit
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
cognitive scorer at two years corrected age
Time Frame: 2 year
|
measured by Bayley Scales of Infant Development Third Edition (BSID III)
|
2 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in heart rate
Time Frame: 24 hours
|
24 hours
|
|
change in body temperature
Time Frame: 24 hours
|
24 hours
|
|
change in respiration frequency
Time Frame: 24 hours
|
24 hours
|
|
change in blood glucose
Time Frame: 24 hours
|
24 hours
|
|
general movements (GM) at 3 months corrected age
Time Frame: 3 months
|
assessed with the General Movement Assessment (GMA)
|
3 months
|
Nutrition
Time Frame: 1 year
|
based on a Norwegian questionnaire, based on a Norwegian national survey from The Norwegian Directorate of Health.
|
1 year
|
Social/emotional competence at three months corrected age
Time Frame: 3 months
|
measured with the Ages and Stages Questionnaire: Social Emotional (ASQ:SE)
|
3 months
|
Social/emotional competence at two years corrected age
Time Frame: 1 year
|
measured with the Ages and Stages Questionnaire: Social Emotional (ASQ:SE)
|
1 year
|
Social/emotional competence at two years corrected age
Time Frame: 2 years
|
measured with the Ages and Stages Questionnaire: Social Emotional (ASQ:SE)
|
2 years
|
Developmental skills at two years corrected age
Time Frame: 1 year
|
measured with the Ages and Stages Questionnaire: (ASQ)
|
1 year
|
Developmental skills at two years corrected age
Time Frame: 2 years
|
measured with the Ages and Stages Questionnaire: (ASQ)
|
2 years
|
Maternal anxiety
Time Frame: at discharge from hospital
|
measured with State-Trait Anxiety Inventory (STAI)
|
at discharge from hospital
|
Maternal anxiety
Time Frame: 3 months
|
measured with State-Trait Anxiety Inventory (STAI)
|
3 months
|
Maternal anxiety
Time Frame: 2 years
|
measured with State-Trait Anxiety Inventory (STAI)
|
2 years
|
Child Behaviour
Time Frame: 5 year
|
Measured with Child Behaviour Checklist
|
5 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Håkon Bergseng, md phd, Norwegian University of Science and Technology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2014
Primary Completion (Actual)
December 31, 2022
Study Completion (Anticipated)
December 1, 2025
Study Registration Dates
First Submitted
December 19, 2013
First Submitted That Met QC Criteria
December 28, 2013
First Posted (Estimate)
December 31, 2013
Study Record Updates
Last Update Posted (Actual)
January 20, 2023
Last Update Submitted That Met QC Criteria
January 19, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KC28-32
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Birth
-
Shaare Zedek Medical CenterTerminatedPremature Birth of NewbornIsrael
-
University of VirginiaCompletedPremature Birth of NewbornUnited States
-
Case Western Reserve UniversityCompleted
-
University of California, San FranciscoUniversity of California, San Diego; University of California, Los Angeles; Kaiser...CompletedPremature Birth of NewbornUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknownPremature Birth of NewbornBelgium
-
Universidad Complutense de MadridCompletedPremature Birth of Newborn
-
Indiana UniversityCompletedPremature LaborUnited States
-
Washington University School of MedicineUniversity of Southern CaliforniaCompletedPremature Birth of NewbornUnited States
-
Vestre Viken Hospital TrustHaukeland University HospitalActive, not recruiting
-
University of ArkansasCompletedPremature Birth of NewbornUnited States
Clinical Trials on standard care
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
University of OklahomaNational Cancer Institute (NCI)CompletedSmoking CessationUnited States
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
University of MichiganCompleted
-
University of OklahomaCompletedTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency ManagementUnited States
-
University of OklahomaEnrolling by invitationTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency Management | PregnancyUnited States
-
Institut de Cancérologie de LorraineTerminatedBreast CancerFrance
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
Johns Hopkins UniversityRecruitingCompartment Syndrome of Leg | Extracorporeal Membrane Oxygenation Complication | Limb Ischemia, Critical | Limb IschemiaUnited States